← Latest Filings
W
Weiss Asset Management LP
Also a 13F filer: see its fund portfolio and quarterly moves →
Open-market buys
0
$0 total
Open-market sells
1
$233.4M total
Tracking since
Feb 2026
Activity timeline
Open-market sale — $233.4M
AVADEL PHARMACEUTICALS PLC · Feb 13, 2026
Open-market trades from the last two years.
Holdings as last reported
11,112,052 Ordinary Shares in AVDL
Held indirectly (See Footnote 1) · as of 2026-02-11
Companies touched
Avadel Pharmaceuticals Ltd
CIK 0001012477
Theravance Biopharma, Inc.
CIK 0001583107